Practice
Featured experience
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
EquipmentShare $860 million IPO
We advised EquipmentShare on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Baker Hughes €3 billion senior notes offering
We advised the underwriters on the investment-grade notes offering
Robinhood Ventures Fund I IPO and NYSE listing
We advised Robinhood on the establishment of Robinhood Ventures and the IPO and NYSE listing of Robinhood Ventures Fund I
Western Union $450 million notes offering
We advised the joint book-running managers on the investment-grade debt offering
Abbott Laboratories $20 billion notes offering
We advised the joint book-running managers on the offering
Mizrahi Tefahot Bank $700 million senior notes offering
We advised Mizrahi Tefahot Bank on the offering
Mizrahi Tefahot Bank $750 million Tier 2 subordinated notes
We advised Mizrahi Tefahot Bank on a Rule 144A / Regulation S Tier 2 subordinated debt offering
Oculis Holding $100 million at-the-market offering
We advised the sales agent on the offering
indie Semiconductor $150 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
BBVA $2.5 billion senior non-preferred notes offering
We advised BBVA on its offering of senior non-preferred notes
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever